Literature DB >> 32767057

The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.

Karthik Shanbhag1, Amol Mhetre1, Neha Khandelwal1, Siddhesh S Kamat2.   

Abstract

Lysophospholipids are potent hormone-like signalling biological lipids that regulate many important biological processes in mammals (including humans). Lysophosphatidic acid and sphingosine-1-phosphate represent the best studied examples for this lipid class, and their metabolic enzymes and/or cognate receptors are currently under clinical investigation for treatment of various neurological and autoimmune diseases in humans. Over the past two decades, the lysophsophatidylserines (lyso-PSs) have emerged as yet another biologically important lysophospholipid, and deregulation in its metabolism has been linked to various human pathophysiological conditions. Despite its recent emergence, an exhaustive review summarizing recent advances on lyso-PSs and the biological pathways that this bioactive lysophospholipid regulates has been lacking. To address this, here, we summarize studies that led to the discovery of lyso-PS as a potent signalling biomolecule, and discuss the structure, its detection in biological systems, and the biodistribution of this lysophospholipid in various mammalian systems. Further, we describe in detail the enzymatic pathways that are involved in the biosynthesis and degradation of this lipid and the putative lyso-PS receptors reported in the literature. Finally, we discuss the various biological pathways directly regulated by lyso-PSs in mammals and prospect new questions for this still emerging biomedically important signalling lysophospholipid.

Entities:  

Keywords:  GPCR; Lipases; Lysophosphatidylserine; Macrophage efferocytosis; Mast cell degranulation; TLR2

Year:  2020        PMID: 32767057      PMCID: PMC7116134          DOI: 10.1007/s00232-020-00133-2

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  155 in total

1.  The relationship of the tissue mast cells to the blood vessels in the rat.

Authors:  J F RILEY
Journal:  J Pathol Bacteriol       Date:  1953-04

2.  The preparation and properties of lysophosphatidylserine.

Authors:  L RATHBONE; W L MAGEE; R H THOMPSON
Journal:  Biochem J       Date:  1962-06       Impact factor: 3.857

3.  Novel ABHD12 mutations in PHARC patients: the differential diagnosis of deaf-blindness.

Authors:  Hidekane Yoshimura; Takao Hashimoto; Toshinori Murata; Kunihiro Fukushima; Akiko Sugaya; Shin-Ya Nishio; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-05       Impact factor: 1.547

Review 4.  Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.

Authors:  Hugh Rosen; Edward J Goetzl
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

5.  Gαs-coupled GPCRs GPR65 and GPR174. Downers for immune responses.

Authors:  Remy Robert; Charles R Mackay
Journal:  Immunol Cell Biol       Date:  2018-03-14       Impact factor: 5.126

Review 6.  Emerging roles for lysophosphatidylserine in resolution of inflammation.

Authors:  S Courtney Frasch; Donna L Bratton
Journal:  Prog Lipid Res       Date:  2012-03-29       Impact factor: 16.195

7.  Ca2+ influx, phosphoinositide hydrolysis, and histamine release induced by lysophosphatidylserine in mast cells.

Authors:  S Lloret; J J Moreno
Journal:  J Cell Physiol       Date:  1995-10       Impact factor: 6.384

Review 8.  Efferocytosis in health and disease.

Authors:  Amanda C Doran; Arif Yurdagul; Ira Tabas
Journal:  Nat Rev Immunol       Date:  2019-12-10       Impact factor: 53.106

9.  Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3.

Authors:  Tobias Eisenberger; Rima Slim; Ahmad Mansour; Markus Nauck; Gudrun Nürnberg; Peter Nürnberg; Christian Decker; Claudia Dafinger; Inga Ebermann; Carsten Bergmann; Hanno Jörn Bolz
Journal:  Orphanet J Rare Dis       Date:  2012-09-02       Impact factor: 4.123

10.  Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet.

Authors:  Bo Wang; Xin Rong; Mark A Duerr; Daniel J Hermanson; Per Niklas Hedde; Jinny S Wong; Thomas Q de Aguiar Vallim; Benjamin F Cravatt; Enrico Gratton; David A Ford; Peter Tontonoz
Journal:  Cell Metab       Date:  2016-01-28       Impact factor: 27.287

View more
  10 in total

1.  Increase in Cellular Lysophosphatidylserine Content Exacerbates Inflammatory Responses in LPS-Activated Microglia.

Authors:  Tomoki Minamihata; Katsura Takano; Yoichi Nakamura; Ryoya Seto; Mitsuaki Moriyama
Journal:  Neurochem Res       Date:  2021-08-12       Impact factor: 4.414

2.  Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs.

Authors:  Neha Khandelwal; Minhaj Shaikh; Amol Mhetre; Shubham Singh; Theja Sajeevan; Alaumy Joshi; Kithiganahalli Narayanaswamy Balaji; Harinath Chakrapani; Siddhesh S Kamat
Journal:  Cell Chem Biol       Date:  2021-02-10       Impact factor: 8.116

3.  Metabolomics in early life and the association with body composition at age 2 years.

Authors:  Inge A L P van Beijsterveldt; Stuart G Snowden; Pernille Neve Myers; Kirsten S de Fluiter; Bert van de Heijning; Susanne Brix; Ken K Ong; David B Dunger; Anita C S Hokken-Koelega; Albert Koulman
Journal:  Pediatr Obes       Date:  2021-10-13       Impact factor: 3.910

4.  Lysophosphatidylserine Induces MUC5AC Production via the Feedforward Regulation of the TACE-EGFR-ERK Pathway in Airway Epithelial Cells in a Receptor-Independent Manner.

Authors:  Myeong Seong Sim; Hye Jeong Kim; Sang Hee Jo; Chun Kim; Il Yup Chung
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

Review 5.  Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases.

Authors:  Mayssa Hachem; Houda Nacir
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

6.  Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.

Authors:  Jessica I Sanchez; Jingjing Jiao; Suet-Ying Kwan; Lucas Veillon; Marc O Warmoes; Lin Tan; Mobolaji Odewole; Nicole E Rich; Peng Wei; Philip L Lorenzi; Amit G Singal; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2021-07-12

7.  The loss of enzymatic activity of the PHARC-associated lipase ABHD12 results in increased phagocytosis that causes neuroinflammation.

Authors:  Shubham Singh; Siddhesh S Kamat
Journal:  Eur J Neurosci       Date:  2021-11-11       Impact factor: 3.698

Review 8.  Small Endogenous Ligands Modulation of Nerve Growth Factor Bioactivity: A Structural Biology Overview.

Authors:  Francesca Paoletti; Doriano Lamba
Journal:  Cells       Date:  2021-12-08       Impact factor: 6.600

9.  Molecular Interplay at the Membrane and Impact on Cellular Physiology.

Authors:  Thomas Pucadyil; Kiran Kulkarni; Durba Sengupta
Journal:  J Membr Biol       Date:  2021-05-26       Impact factor: 1.843

Review 10.  Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid.

Authors:  Jumpei Omi; Kuniyuki Kano; Junken Aoki
Journal:  Cell Biochem Biophys       Date:  2021-06-15       Impact factor: 2.194

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.